VistaGen Therapeutics (VTGN) Earnings Date, Estimates & Call Transcripts $2.25 -0.13 (-5.46%) Closing price 07/15/2025 04:00 PM EasternExtended Trading$2.33 +0.08 (+3.56%) As of 04:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VistaGen Therapeutics Earnings Summary VistaGen Therapeutics released Q4 2025 earnings on June 17, 2025, reporting an EPS of -$0.43, which topped analysts' consensus estimates of -$0.52 by $0.09. Quarterly revenue was reported to be ($0.01) million, below the consensus estimate of $0.18 million. With a trailing EPS of -$1.66, VistaGen Therapeutics' earnings are expected to grow next year, from ($1.77) to ($1.74) per share. Upcoming Q1 Earnings DateAug. 12Before Market OpensEstimatedConsensus EPS (Jun. 17) -$0.52 Actual EPS (Jun. 17) -$0.43 Beat By $0.09 Actual Revenue (Jun. 17) -$0.01MQ4 2025 Earnings ResourcesQ4 2025 Earnings ReportConference Call Transcript & Audio Annual Report (10-K) Press Release (8-K)VTGN Upcoming EarningsVistaGen Therapeutics' Q1 2026 earnings is scheduled for Tuesday, August 12, 2025, with a conference call scheduled at 5:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q1 2026 Earnings ReportPowered by Get VistaGen Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on VistaGen Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataVTGN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VTGN Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. VistaGen Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.41-$0.41-$0.41Q2 20251-$0.39-$0.39-$0.39Q3 20251-$0.48-$0.48-$0.48Q4 20251-$0.57-$0.57-$0.57 FY 2025 4 -$1.85 -$1.85 -$1.85 Q1 20261-$0.44-$0.44-$0.44Q2 20261-$0.47-$0.47-$0.47Q3 20261-$0.24-$0.24-$0.24Q4 20261-$0.25-$0.25-$0.25 FY 2026 4 -$1.40 -$1.40 -$1.40 Q1 20271-$0.37-$0.37-$0.37Q2 20271-$0.43-$0.43-$0.43Q3 20271-$0.48-$0.48-$0.48Q4 20271-$0.41-$0.41-$0.41 VistaGen Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/12/2025(Estimated)-------6/17/2025Q4 2025-$0.52-$0.43+$0.09-$0.43$0.18M-$0.01M2/13/2025Q3 2025-$0.48-$0.46+$0.02-$0.46$0.18M$230.00B11/7/2024Q2 2025-$0.40-$0.42 -$0.02-$0.42$0.34M$0.18M8/13/2024Q1 2025-$0.41-$0.35+$0.06-$0.35$0.30M$0.08M6/11/2024Q4 2024-$0.34-$0.25+$0.09-$0.25$0.41M$0.20M2/13/2024Q3 2024-$0.31-$0.22+$0.09-$0.22$0.73M$0.41M11/9/2023Q2 2024--$0.66--$0.66-$0.28M8/10/2023Q1 2024--$0.94--$0.94-$0.18M VistaGen Therapeutics Earnings - Frequently Asked Questions When is VistaGen Therapeutics' earnings date? VistaGen Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 12th, 2025 based off last year's report dates. Learn more on VTGN's earnings history. Did VistaGen Therapeutics beat their earnings estimates last quarter? In the previous quarter, VistaGen Therapeutics (NASDAQ:VTGN) reported ($0.43) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.52) by $0.09. Learn more on analysts' earnings estimate vs. VTGN's actual earnings. How can I listen to VistaGen Therapeutics' earnings conference call? The conference call for VistaGen Therapeutics' latest earnings report can be listened to online. Listen to Conference Call How can I read VistaGen Therapeutics' conference call transcript? The conference call transcript for VistaGen Therapeutics' latest earnings report can be read online. Read Transcript How much revenue does VistaGen Therapeutics generate each year? VistaGen Therapeutics (NASDAQ:VTGN) has a recorded annual revenue of $486,000.00. How much profit does VistaGen Therapeutics generate each year? VistaGen Therapeutics (NASDAQ:VTGN) has a recorded net income of -$51.42 million. VTGN has generated -$1.66 earnings per share over the last four quarters. What is VistaGen Therapeutics' EPS forecast for next year? VistaGen Therapeutics' earnings are expected to grow from ($1.77) per share to ($1.74) per share in the next year. More Earnings Resources from MarketBeat Related Companies Esperion Therapeutics Earnings Date biote Earnings Date ProQR Therapeutics Earnings Date Acelyrin Earnings Date Monopar Therapeutics Earnings Date SELLAS Life Sciences Group Earnings Date Editas Medicine Earnings Date Design Therapeutics Earnings Date scPharmaceuticals Earnings Date MediWound Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles 3 Analysts Set $600 Target Ahead of Microsoft EarningsTesla: 2 Plays Ahead of Next Week's Earnings ReportFastenal Surges After Earnings Beat, Tariff Risks Loom3 Catalysts Converge on Intel Ahead of a Critical Earnings ReportSmith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting CycleBroadcom Slides on Solid Earnings, AI Outlook Still Strong This page (NASDAQ:VTGN) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VistaGen Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share VistaGen Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VTGN Stock Alerts